meningococcal polysaccharide vaccine (MPSV4)

Known as: Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combination, Meningococcal Polysaccharide Vaccine MPS-4, Meningococcal Polysaccharide Vaccine MPSV-4 
A polysaccharide vaccine used to prevent contraction of meningococcal meningitis.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1938-2017
010020030019382016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Neisseria meningitidis binds factor H (fH), a key regulator of the alternative complement pathway. A approximately 29 kD fH… (More)
  • table I
  • table II
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The meningococcal serogroup C conjugate (MCC) vaccine programme in England has successfully controlled the incidence of serogroup… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
A single-tube 5' nuclease multiplex PCR assay was developed on the ABI 7700 Sequence Detection System (TaqMan) for the detection… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menactra, manufactured by Sanofi… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Patients with meningococcal sepsis generally suffer from disseminated intravascular coagulation (DIC). The aim of this study was… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
CONTEXT Data are limited and conflicting regarding the effectiveness of influenza vaccine in health care professionals… (More)
  • figure I
  • table 1
  • table 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND To assess the genetic influence on cytokine production and its contribution to fatal outcome, we determined the… (More)
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 3
Is this relevant?
Highly Cited
1991
Highly Cited
1991
For more than 15 years, Norway has had the highest incidence of meningococcal disease in northern Europe, with 80% of cases being… (More)
Is this relevant?
Highly Cited
1983
Highly Cited
1983
Glycopeptides containing polysialic acid units were isolated from human and rat brain and tested for reactivity with antibodies… (More)
Is this relevant?
Highly Cited
1969
Highly Cited
1969
Purified meningococcal polysaccharides were administered to army recruits. No adverse reactions were observed in 145 men who… (More)
  • table I
  • figure 1
  • table I
  • table III
  • table IV
Is this relevant?